Search

Author/Creator Lazzarotto, D.

1. Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. (April 2023)

Authors:
Maurillo, L.; Spagnoli, A.; Candoni, A.; Papayannidis, C.; Borlenghi, E.; Lazzarotto, D.; Fianchi, L.; Sciumè, M.; Zannier, M.E.; Buccisano, F.; Del Principe, M.I.; Mancini, V.; Breccia, M.; Fanin, R.; Todisco, E.; Lunghi, M.; Palmieri, R.; Fracchiolla, N.; Musto, P.; Rossi, G.
Journal:
Leukemia research
Issue:
Volume 127(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1709: FERTILITY PRESERVATION FOR YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIAS IN ITALY: A CAMPUS ALL SURVEY. (23rd June 2022)

Authors:
Giglio, F.; Bruno, A.; Dargenio, M.; Cerrano, M.; Del Principe, M. I.; Forghieri, F.; Fumagalli, M.; Guolo, F.; Imovilli, A.; Lunghi, M.; Mazzone, C.; Papayannidis, C.; Pasciolla, C.; Trappolini, S.; Lazzarotto, D.; Bonifacio, M.; Candoni, A.; Ciceri, F.; Pizzolo, G.; Vitale, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P357: MULTICENTER RETROSPECTIVE ANALYSIS OF CLINICAL OUTCOME OF ADULT PATIENS WITH MIXED-PHENOTYPE ACUTE LEUKEMIA (MPAL) DIAGNOSED AND TREATED IN THE LAST TEN YEARS. A CAMPUS-ALL STUDY. (23rd June 2022)

Authors:
Lazzarotto, D.; Tanasi, I.; Vitale, A.; Piccini, M.; Dargenio, M.; Giglio, F.; Forghieri, F.; Fracchiolla, N.; Cerrano, M.; Todisco, E.; Papayannidis, C.; Leoncin, M.; Defina, M.; Guolo, F.; Pasciolla, C.; Delia, M.; Chiusolo, P.; Mulè, A.; Candoni, A.; Bonifacio, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P517: PROSPECTIVE MULTICENTRIC STUDY ON INFECTIOUS COMPLICATIONS AND CLINICAL OUTCOME IN 230 UNFIT AML PATIENTS TREATED IN FIRST-LINE WITH HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX. (23rd June 2022)

Authors:
Candoni, A.; Piccini, M.; Lazzarotto, D.; Bonuomo, V.; Dargenio, M.; Riva, M.; Mellillo, L.; Papayannidis, C.; Stulle, M.; Dragonetti, G.; Del Principe, M. I.; Cattaneo, C.; Pasciolla, C.; De Marchi, R.; Delia, M.; Tisi, M. C.; Zannier, M. E.; Nadali, G.; Sciumè, M.; Spadea, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search